📰
Biotech news
The latest Biotech headlines, refreshed daily. Want this for any topic, as a dataset? Monitor it automatically with the Google News Scraper.
Pfizer inks $500M Enodia pact to join Lilly in emerging protein degrader field
Fierce Biotech · 10/13/2026
Biotech builder Paragon imports Apogee's top brass after AbbVie buyout
Fierce Biotech · 10/13/2026
Biotech start-ups turn to reverse mergers to fast-track listings
Financial Times · 10/13/2026
Boston biotech conference website is actually a front for criminal malware group
The Business Journals · 10/11/2026
The Argument For Biotech M&A To Reignite... And Soon
Investor's Business Daily · 10/13/2026
Amid the Biotech Madness, I Spotted an Opening in a Promising Small-Cap
RealMoney Pro · 10/12/2026
Moderna Is Now Worth More Than 3X as Much as BioNTech. Which Biotech Stock Is the Smarter Pick?
The Motley Fool · 10/13/2026
Stocktwits Pharma Pulse: JNJ Earnings, Cancer Updates And Two FDA Target Dates — The Week’s Biotech Watchlist
Yahoo Finance · 10/12/2026
Zuckerberg’s Big Biotech Moment
The Information · 10/10/2026
Healthcare, biotech, pharma are key diversifiers as AI disrupts digital economy – UBS (SP500:)
Seeking Alpha · 10/12/2026
Bambusa and Aspen join biotech IPO queue
The Pharma Letter · 10/13/2026
Parkinson’s-focused Aspen and bispecific biotech Bambusa plan IPOs
Fierce Biotech · 10/13/2026
Biotech’s Rebound Reality: Surging M&A Deals Meet Deep Retail Skepticism
ETF Database · 10/12/2026
Leisa Talbert Peschel Featured in Bloomberg Law Discussing Hospital–Biotech Partnerships in IP Litigation
Jackson Walker LLP · 10/12/2026
Baltimore VC stays steady on deal count in Q3, as capital remains concentrated at the top
Technical.ly · 10/13/2026
Horizon Space Acquisition and ArcheNova Biotech announce merger
TradingView · 10/13/2026
Sibylla Biotech Appoints Usman Azam CEO, Gianluca Fuggetta
GlobeNewswire · 10/13/2026
One dose of VERAXA's two-part cancer treatment shrank tumors in a breast cancer model
Stock Titan · 10/13/2026
TCRT Stock Surges As Traders Target Biotech Rebound
StocksToTrade · 10/13/2026
Biotech Stocks At 52-Week Highs - RTSN Rises With IPO, BIIB, CON, HNGE, HSTM
RTTNews · 10/13/2026
BioNTech’s mRNA cancer vaccine fails phase 3 test, significantly denting analysts’ confidence
Fierce Biotech · 10/13/2026
Track Biotech — or any topic — automatically
Get fresh articles as a dataset (JSON/CSV), on a schedule.
▶ Open Google News Scraper